Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)

To evaluate the safety and effectiveness of Ivonescimab combined with intraperitoneal paclitaxel (IP PTX) in patients with unresectable metastatic high-grade A…

Phase IIIvonescimabIntraperitoneal+3 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07753824